Q1 2020 ImpediMed Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the ImpediMed quarterly results investor call. (Operator Instructions)
I would now like to hand the conference over to Mr. Rick Carreon, Managing Director and CEO. Please go ahead.
Thank you, Chantel, and welcome, everyone. Thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial year quarter ending 30 September 2019. Our Vice President of Finance, Mr. Tim Cruickshank, will be filling in for Morten Vigeland, our CFO, who is unavailable for today's call.
During our call today, I'll be referencing the 4C we launched earlier this morning in Australian time. As we normally do, I'll take questions following my comments.
This quarter marks a key inflection point for ImpediMed. First of all, Software-as-a-Service became the key revenue and growth generator for the company, and recall, this is a business that is less than 2 years old. Two, we launched the lymphedema
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |